Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

84.48
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
66.93
Today|||52-Week Range
86.90
+15.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line921.9M1.6B2.0B2.1B
 
 
 
 
 
Depreciation985.2M1.8B1.4B1.5B
 
 
 
 
 
Total Other Cash Flow-782.6M12.9M67.6M-142.1M
 
 
 
 
 
Funds From Operations1.1B3.4B3.5B3.5B
 
 
 
 
 
Funds From/For Other Operating Expenses-2.4B1.4B-161.4M-163.2M
 
 
 
 
 
Net Cash Flow - Operating Activities3.5B2.0B3.6B3.6B
 
 
 
 
 
 
InvestingIncrease In Investments-775.3M-14.9M14.9M0.00
 
 
 
 
Decrease In Investments777.9M0.0023.1M-18.1M
 
 
 
 
Capital Expenditures-579.0M-340.8M-339.4M-388.2M
 
 
 
 
 
Fixed Asset Disposal-799.6M349.8M262.1M-270.5M
 
 
 
 
 
Net Assets From Acquisitions -232.1M-653.0M-6.2M-108.4M
 
 
 
 
 
Other Investing - Uses-371.8M-46.6M-41.0M-387.1M
 
 
 
 
 
Other Investing - Sources845.2M0.000.00545.3M
 
 
 
Net Cash Flow Investing-1.1B-1.1B-356.1M-696.9M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings-2.2B7.2B-1.1B-560.1M
 
 
 
 
 
Long Term Debt Reduction--0.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-415.0M-1.0B-1.9B-1.4B
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total29.3M-6.4B-100.4M-23.3M
 
 
 
 
 
Other Sources - Financing220.5M0.0013.1M37.4M
 
 
 
 
Other Uses - Financing-3.0M68.4M-68.4M0.00
 
 
 
 
Net Cash Flow - Financing-2.3B-384.4M-3.0B-2.0B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-381.2M8.9M51.5M-9.9M
 
 
 
 
 
 
Net Change In Cash203.2M550.9M243.1M976.4M